您的当前位置:首页 > 行业数据 > 图13.ZX2021二期临床试验设计(在非糖尿病的超重或肥胖受试者中评价ZX2021注射液的有效性、安全性及药
图片属性
图片格式:PNG 图片大小:583KB 图片尺寸:2339*1184
同报告图片
 / 4
图13.ZX2021二期临床试验设计(在非糖尿病的超重或肥胖受试者中评价ZX2021注射液的有效性、安全性及药_第1页
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
图13.ZX2021二期临床试验设计(在非糖尿病的超重或肥胖受试者中评价ZX2021注射液的有效性、安全性及药_第2页
图13.ZX2021二期临床试验设计(在非糖尿病的超重或肥胖受试者中评价ZX2021注射液的有效性、安全性及药_第3页
图13.ZX2021二期临床试验设计(在非糖尿病的超重或肥胖受试者中评价ZX2021注射液的有效性、安全性及药_第4页
图13.ZX2021二期临床试验设计(在非糖尿病的超重或肥胖受试者中评价ZX2021注射液的有效性、安全性及药_第5页
所属报告: 康缘药业(600557)-A股公司研究报告:“一体两翼”战略价值凸显创新布局未来可期-250804(24页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠